Clene Inc.CLNNNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank59
3Y CAGR-41.4%
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

3Y CAGR
-41.4%/yr
vs -40.8%/yr prior
Acceleration
-0.6pp
Decelerating
Percentile
P59
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
2 qtr
Consecutive growthRecovering
PeriodValue
Q4 20253.72%
Q3 2025-1.96%
Q2 2025-17.43%
Q1 2025-1.56%
Q4 2024-20.95%
Q3 20242.99%
Q2 20246.73%
Q1 2024-6.53%
Q4 20234.56%
Q3 2023-16.35%
Q2 202319.43%
Q1 2023-19.68%
Q4 202218.53%
Q3 2022-20.31%
Q2 2022-4.21%
Q1 2022110.95%
Q4 2021-50.30%
Q3 2021-28.47%
Q2 202140.11%
Q1 2021172.51%
Q4 2020-14.87%
Q3 202076.67%
Q2 202025.12%
Q1 2020238.88%
Q4 2019-91.12%
Q3 2019101.95%
Q2 20190.00%
Q1 20190.00%